Children in Clinical Trials: FDA’s Proposed Rules of Engagement
FDA issued draft guidance on ethical considerations and special safeguards for having children participate in clinical trials. The new statement addresses how to protect children in clinical investigations for drugs, biological products, and medical devices. Some of the fundamental concepts that the new guidance included for consideration by industry, sponsors, and institutional review boards (IRBs) […]